Search
What All Lawyers Need To Know About The State Of Immigration Law This white paper explores some of the biggest challenges you can expect to face when practicing immigration law. By ABOVE THE LAW AND EMBROKER
Controversial US Visa Draws Rich From China to India After Reset The EB-5 visa program coveted by many wealthy overseas investors is being revived after changes aimed at curbing abuses. By Blake Schmidt
CRE Investment Hot Streak Doused By Down Economy Economic forces at play across the globe, including the rising cost of capital and the threat of a U.S. recession have caused investors to think twice about how and where to place their money, with several leading indicators of deal volume slipping...
FUND ADMINISTRATION VS. ANNUAL AUDIT Rohit Kapuria, a Partner in the Firm's EB-5 Practice, will speak during a JTC Americas webinar. On 6/24/22, a federal court granted a preliminary injunction in the case of Behring Regional Center, LLC, v. Alejandro Mayorkas, et al., overturning the USCIS’s...
NEXT STEPS FOR INVESTORS AND DETAILS ON SALTAIRE (URBAN) & TWIN LAKES (RURAL) PROJECTS Rohit Kapuria, a Partner in the Firm's EB-5 Practice, to speak at an EB5 Affiliate Network Webinar. The webinar will cove the current state of the EB-5 Regional Center Program following the recent court ruling...
Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...
Veronica McCarty is a litigator who represents inventors and companies in intellectual property disputes, particularly for inventions involving computing and biopharmaceutical technologies, as well as medical devices. Veronica works on patent trials, including on ANDA bench trials, and she assists...
Industry-Specific, Business-Focused Legal Advice Increased pricing pressure combined with a rise in generic competition and continued regulatory uncertainty have squeezed the margins of life sciences companies. Helping navigate this ever-shifting terrain, Saul Ewing’s Life Sciences Practice consists...
Caroline Patterson brings more than 25 years of legal experience to her work representing practices and professionals in the health care industry in a variety of transactional, corporate, and regulatory matters. Her experience ranges from providing counsel in mergers, acquisitions, sales and private...
David Berk counsels families and their businesses, entrepreneurs and start-up companies in taxation, structuring transactions, contract negotiations and governance issues. David also advises clients on corporate succession planning, trust and estate planning, insurance and retirement planning and...
Jeffrey Letwin counsels businesses in complex matters including corporate finance, mergers and acquisitions, franchising, real estate finance and development. He also advises enterprises in the interface between governmental and economic development agencies and devises financing strategies...
Eric Orlinsky co-chairs the firm's Corporate Practice and its Private Equity/Venture Capital subgroup and concentrates his practice in general business and securities law and counsels clients in private equity and venture capital investments, public and private offerings of debt and equity...
Mark Simpson counsels technology and intellectual property innovators to assist them in developing, protecting, and monetizing the results of their creative endeavors, with a focus on IP strategy and branding. He protects their IP assets via patent preparation and prosecution, IP counseling and...
Barry F. Levin provides high-level legal counsel on complex corporate and real estate transactions that shape the future of businesses across a wide variety of industries. His keen understanding of how legal issues intersect with business interests in these deals and other corporate matters stems...
Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...